OSL.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:10):

Stats
Dzisiejszy wolumen	1.14M
Średni wolumen	3.26M
Kapitalizacja rynkowa	14.81M
EPS	$0 ( 2024-02-25 )
Następna data zysków	( $0 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.400
ATR14	$0 (0.00%)

Oncosil Medical Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncosil Medical Ltd Finanse

Annual	2023
Przychody:	$367 677
Zysk brutto:	$-6.49M (-1 766.30 %)
EPS:	$-0.00950

FY	2023
Przychody:	$367 677
Zysk brutto:	$-6.49M (-1 766.30 %)
EPS:	$-0.00950

FY	2022
Przychody:	$231 789
Zysk brutto:	$-6.73M (-2 902.18 %)
EPS:	$-0.0102

FY	2021
Przychody:	$213 070
Zysk brutto:	$-747 953 (-351.04 %)
EPS:	$-0.0159

Financial Reports:

No articles found.

Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.